Rossari Biotech Posts Q2 FY27 Results; Approves KSA Greenfield Land Lease
Rossari Biotech Ltd · Others (Uncategorized) · 18 Oct 2026, 1:04 am
Rossari Biotech Posts Q2 FY27 Results; Approves KSA Greenfield Land Lease Rossari Biotech reported Q2 FY27 consolidated revenue of ₹6,975.60 mn, up 19.0% YoY, with net profit rising 5.5% YoY to ₹389.07 mn. Diluted EPS stood at ₹7.02 versus ₹6.65 in Q2 FY26. For H1 FY27, revenue reached ₹13,947.60 mn and PAT increased to ₹740.02 mn. In a key strategic move, the board approved the leasing of land by wholly owned subsidiary Rossari International Company Limited to establish a greenfield manufacturing facility in Saudi Arabia, with project details and capex pending finalization.
Original exchange filing (PDF)
More announcements from Rossari Biotech Ltd
- Intimation of Transcript of Q2 & H1 FY27 for the Earnings Conference Call held on October 19, 2026 · 23 Oct 2026
- Audio recording of Earnings Conference Call for Q2 & H1 FY 27. · 20 Oct 2026
- Press Release for Q2 FY27 Results · 19 Oct 2026
- Intimation of Q2 & H1 FY27- Earnings Presentation · 19 Oct 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026. · 18 Oct 2026
- Outcome of Board Meeting held on October 17, 2026. · 18 Oct 2026
- Outcome of Board Meeting Held On October 17, 2026 · 18 Oct 2026
- Intimation of Earnings Conference Call for investor and analyst on Monday, October 19, 2026 at 04:00 P.M. (IST). · 19 Oct 2026
